These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35427376)

  • 21. Photoselective vaporization for the treatment of benign prostatic hyperplasia.
    Bowen JM; Whelan JP; Hopkins RB; Burke N; Woods EA; McIsaac GP; O'Reilly DJ; Xie F; Sehatzadeh S; Levin L; Mathew SP; Patterson LL; Goeree R; Tarride JE
    Ont Health Technol Assess Ser; 2013; 13(2):1-34. PubMed ID: 24019857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Minimally Invasive Procedures for Benign Prostatic Hyperplasia: A Cost-effectiveness Analysis.
    Wu X; Zhou A; Heller M; Chi T; Kohlbrenner R
    Radiology; 2023 Dec; 309(3):e230555. PubMed ID: 38085076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials.
    Zang YC; Deng XX; Yang DR; Xue BX; Xu LJ; Liu XL; Zhou YB; Shan YX
    Lasers Med Sci; 2016 Feb; 31(2):235-40. PubMed ID: 26712715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms: A Markov Model-Based Cost-Effectiveness Analysis.
    Rink JS; Froelich MF; McWilliams JP; Gratzke C; Huber T; Gresser E; Schoenberg SO; Diehl SJ; Nörenberg D
    J Am Coll Radiol; 2022 Jun; 19(6):733-743. PubMed ID: 35476943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies.
    Lai S; Peng P; Diao T; Hou H; Wang X; Zhang W; Liu M; Zhang Y; Seery S; Wang J
    BMJ Open; 2019 Aug; 9(8):e028855. PubMed ID: 31439603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Private Payer and Patient Out-of-Pocket Costs Associated With the Surgical Management of Benign Prostatic Hyperplasia.
    Wymer KM; Thao V; Narang G; Sharma V; Borah BJ; Cheney S; Humphreys MR
    Urology; 2024 Feb; 184():87-93. PubMed ID: 38065310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis.
    Lucas-Cava V; Sánchez-Margallo FM; Insausti-Gorbea I; Sun F
    BJU Int; 2023 Feb; 131(2):139-152. PubMed ID: 35417622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the Economics of Surgical Treatment Options for Benign Prostatic Hyperplasia.
    Aladesuru O; Punyala A; Stoddard M; Bhojani N; Zorn K; Elterman D; Chughtai B
    Curr Urol Rep; 2022 Jan; 23(1):11-18. PubMed ID: 35156176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials.
    Zhou Y; Xue B; Mohammad NA; Chen D; Sun X; Yang J; Dai G
    Lasers Med Sci; 2016 Apr; 31(3):485-95. PubMed ID: 26868032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Ulchaker JC; Martinson MS
    Clinicoecon Outcomes Res; 2018; 10():29-43. PubMed ID: 29343977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
    Eure G; Rukstalis D; Roehrborn C
    J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
    [No Abstract]   [Full Text] [Related]  

  • 40. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis.
    Teng J; Zhang D; Li Y; Yin L; Wang K; Cui X; Xu D
    BJU Int; 2013 Feb; 111(2):312-23. PubMed ID: 23145474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.